About Careers MedBlog Contact us

Early Detection of Cancer by DNA Rings Proved in Mice

by Julia Samuel on February 25, 2015 at 12:07 PM
Font : A-A+

Early Detection of Cancer by DNA Rings Proved in Mice

Early detection of cancer by an advanced method using tiny customised DNA rings was developed by India-born physician-scientist Sanjiv Sam Gambhir and his colleagues.

Stanford University School of Medicine investigators inserted tiny DNA rings into the genes of mice, which caused cancer cells to emit a substance that could be detected from a blood sample.


A blood-detectable biomarker is encoded in the DNA rings, and can enter both healthy cells and cancer cells. But only cancer cells follow the steps to make the biomarker.

"The challenge for those kinds of biomarkers is that they're rarely very specific and often not made in sufficient quantities," Sanjiv Sam Gambhir, professor and chair of radiology and director of the Canary Centre at Stanford for Cancer Early Detection, said.

The scientists, by a blood test, showed a marker that was detected 48 hours after the mice with tumours produced. This marker was not produced the mice that did not have the tumour.

The DNA minicircles are comprised of tiny rings of DNA and turn on the cell's machinery to make RNA. The RNA makes a protein, which then serves as a cancer biomarker. Embryonic alkaline phosphatase (SEAP) is the marker in this case.

Gambhir said, "We want to translate this strategy into humans, so we've set it up in a way that's most likely to be effective, safe and convenient".

He added, "Although the minicircles were injected intravenously to the mice in this study, it should eventually prove possible to deliver them orally via a pill. We haven't got it down to a pill yet, but the oral delivery part of this is likely a solvable problem only a few years off, not five or 10 years off."

Gambhir cautioned that it would take much more time than that to prove that the approach was safe to use in humans, though.

Source: Medindia


Recommended Reading

Latest Cancer News

Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Are Biomarkers the Key to Identifying Early Pancreatic Risk?
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
How Does New Drugs Work Together to Reduce Lung Tumors?
New combination of medications trametinib and entinostat were found to decrease lung cancer in mice.
New Combination Therapy Proves Effective Against Prostate Cancer
Combination treatment with TALZENNA and XTANDI was found to benefit prostate cancer patients, revealed study.
Can Vitamin A Rich Diet Help Reduce Pancreatitis Risk
In leukemia patients, reduced amounts of dietary vitamin A is associated with a higher risk and severity of pancreatitis.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Early Detection of Cancer by DNA Rings Proved in Mice Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests